Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Scienture Holdings, Inc. (SCNX)

Compare
1.3400
-0.1000
(-6.94%)
At close: 4:00:01 PM EDT
1.3600
+0.02
+(1.49%)
After hours: 4:47:17 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for SCNX

Recent News: SCNX

View More
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization
GlobeNewswire 7 days ago
Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days

Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days
GlobeNewswire 13 days ago
SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.
GlobeNewswire 14 days ago
SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.

SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.
GlobeNewswire 26 days ago
Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics

Scienture Holdings, Inc. Announces Dr. Narasimhan Mani’s Participation in the 8th Annual Conference of The Society for the Study of Xenobiotics
GlobeNewswire 2 months ago
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025

Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025
GlobeNewswire 3 months ago
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
GlobeNewswire 3 months ago
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement

Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
GlobeNewswire 4 months ago
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
GlobeNewswire 6 months ago
View More

Related Tickers

WGRX Wellgistics Health, Inc. Common Stock
4.5700
+5.79%
 
RDGT China Jo-Jo Drugstores, Inc.
1.0300
-1.90%
 
HKPD Hong Kong Pharma Digital Technology Holdings Limited
1.1100
+2.78%
 
TWY.SG Alibaba Health Information Technology Limited
0.5522
+2.79%
 
1J5.SI Hyphens Pharma International Limited
0.2850
0.00%
 
APOTEA.ST Apotea AB
71.92
-1.32%
 
DOCM.SW DocMorris AG
17.38
+0.93%
 
PINK.PR Pilulka Lékárny a.s.
185.00
-4.64%
 
7731.TWO MARX Biotech Co., Ltd.
7.00
-0.28%
 
PETS PetMed Express, Inc.
4.0500
-3.34%